Payment overview · 2025
General Payments
$3,789.35
146 reported records · 18 companies
Healthcare provider profile · identity verified
Matthew Ryan Gossage, M.D.
Allopathic & Osteopathic Physicians|Radiology|Vascular & Interventional Radiology · GREENVILLE, SC · NPI 1750540654
Verified facts
What the public records show
CMS Open Payments records show Matthew Ryan Gossage, M.D. received $3,789.35 in general payments during 2025 across 146 reported records.
Stryker Corporation accounted for 25.2% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 43 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Stryker Corporation | Unresolved — no canonical attribution shown | $954.85 | 25.2% | 27 | 2025 |
| TriSalus Life Sciences, Inc. | Unresolved — no canonical attribution shown | $681.99 | 18.0% | 35 | 2025 |
| Inari Medical, Inc. | Unresolved — no canonical attribution shown | $407.93 | 10.8% | 7 | 2025 |
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$278.15 | 7.3% | 14 | 2025 |
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $264.02 | 7.0% | 8 | 2025 |
| Balt USA, LLC | Unresolved — no canonical attribution shown | $198.56 | 5.2% | 13 | 2025 |
| Terumo Medical Corporation | Unresolved — no canonical attribution shown | $195.57 | 5.2% | 6 | 2025 |
| Cook Medical LLC | Unresolved — no canonical attribution shown | $157.64 | 4.2% | 10 | 2025 |
| W. L. Gore & Associates, Inc. | Unresolved — no canonical attribution shown | $132.81 | 3.5% | 8 | 2025 |
| Imperative Care, Inc | Unresolved — no canonical attribution shown | $124.46 | 3.3% | 3 | 2025 |
| Shockwave Medical, Inc | Unresolved — no canonical attribution shown | $116.31 | 3.1% | 6 | 2025 |
| Delcath Systems | Unresolved — no canonical attribution shown | $108.58 | 2.9% | 1 | 2025 |
| AngioDynamics, Inc. | Unresolved — no canonical attribution shown | $60.12 | 1.6% | 2 | 2025 |
| Cagent Vascular INC | Unresolved — no canonical attribution shown | $23.94 | 0.6% | 2 | 2025 |
| ARGON MEDICAL DEVICES, INC. | Unresolved — no canonical attribution shown | $23.74 | 0.6% | 1 | 2025 |
| Bard Peripheral Vascular, Inc. | Unresolved — no canonical attribution shown | $23.09 | 0.6% | 1 | 2025 |
| INSTYLLA, INC. | Unresolved — no canonical attribution shown | $19.25 | 0.5% | 1 | 2025 |
| CORDIS US CORP. | Unresolved — no canonical attribution shown | $18.34 | 0.5% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $3,789.35 | 146 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| CT THROMBECTOMY SYSTEM KIT Normalized: ct thrombectomy system kit |
Device | Inari Medical, Inc., Stryker Corporation | $814.21 | 24 | 2025 |
Source payment records
|
|||||
| FLOWTRIEVER CATHETER, S Normalized: flowtriever catheter s |
Device | Inari Medical, Inc., Stryker Corporation | $814.21 | 24 | 2025 |
Source payment records
|
|||||
| TRINAV INFUSION SYSTEM Normalized: trinav infusion system |
Device | TriSalus Life Sciences, Inc. | $681.99 | 35 | 2025 |
Source payment records
|
|||||
| FLOWTRIEVER Normalized: flowtriever |
Device | Stryker Corporation | $360.74 | 6 | 2025 |
Source payment records
|
|||||
| Prestige Coil System Normalized: prestige coil system |
Device | Balt USA, LLC | $129.50 | 7 | 2025 |
Source payment records
|
|||||
| AZUR CX DETACHABLE Normalized: azur cx detachable |
Device | Terumo Medical Corporation | $129.43 | 3 | 2025 |
Source payment records
|
|||||
| Axios Normalized: axios |
Device | Boston Scientific Corporation | $128.94 | 1 | 2025 |
Source payment records
|
|||||
| SYMPHONY CATHETER Normalized: symphony catheter |
Device | Imperative Care, Inc | $124.46 | 3 | 2025 |
Source payment records
|
|||||
| Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter Normalized: shockwave ivl system with the shockwave c2 coronary ivl catheter |
Device | Shockwave Medical, Inc | $116.31 | 6 | 2025 |
Source payment records
|
|||||
| HEPZATO KIT Normalized: hepzato kit |
Drug | Delcath Systems | $108.58 | 1 | 2025 |
Source payment records
|
|||||
| HYDROPEARL Normalized: hydropearl |
Device | Terumo Medical Corporation | $107.24 | 1 | 2025 |
Source payment records
|
|||||
| PROGREAT Normalized: progreat |
Device | Terumo Medical Corporation | $107.24 | 1 | 2025 |
Source payment records
|
|||||
| VENACORE THROMBECTOMY CATHETER Normalized: venacore thrombectomy catheter |
Device | Stryker Corporation | $106.09 | 1 | 2025 |
Source payment records
|
|||||
| KYPHON EXPRESS II KYPHOPAK TRAY Normalized: kyphon express ii kyphopak tray |
Device | Medtronic, Inc. | $91.59 | 3 | 2025 |
Source payment records
|
|||||
| EMPRINT Normalized: emprint |
Device | Medtronic, Inc. | $84.31 | 3 | 2025 |
Source payment records
|
|||||
| GORE VIABAHN VBX Balloon Expandable Endo Normalized: gore viabahn vbx balloon expandable endo |
Device | W. L. Gore & Associates, Inc. | $80.61 | 5 | 2025 |
Source payment records
|
|||||
| ROSEN Normalized: rosen |
Device | Cook Medical LLC | $60.58 | 3 | 2025 |
Source payment records
|
|||||
| SMART PORT CT Normalized: smart port ct |
Device | AngioDynamics, Inc. | $60.12 | 2 | 2025 |
Source payment records
|
|||||
| ARTIX MT Normalized: artix mt |
Device | Stryker Corporation | $56.25 | 2 | 2025 |
Source payment records
|
|||||
| MVP Normalized: mvp |
Device | Medtronic, Inc. | $49.75 | 4 | 2025 |
Source payment records
|
|||||
| Revere Hybrid Access Catheter Normalized: revere hybrid access catheter |
Device | Balt USA, LLC | $48.20 | 4 | 2025 |
Source payment records
|
|||||
| EMBOLD Fibered Normalized: embold fibered |
Device | Boston Scientific Corporation | $46.71 | 2 | 2025 |
Source payment records
|
|||||
| R2P MISAGO Normalized: r2p misago |
Device | Terumo Medical Corporation | $43.59 | 2 | 2025 |
Source payment records
|
|||||
| COOK CELECT Normalized: cook celect |
Device | Cook Medical LLC | $41.66 | 3 | 2025 |
Source payment records
|
|||||
| ZILVER PTX Normalized: zilver ptx |
Device | Cook Medical LLC | $38.86 | 3 | 2025 |
Source payment records
|
|||||
| ELUVIA Normalized: eluvia |
Device | Boston Scientific Corporation | $36.72 | 2 | 2025 |
Source payment records
|
|||||
| CONCERTOTM Normalized: concertotm |
Device | Medtronic, Inc. | $34.78 | 2 | 2025 |
Source payment records
|
|||||
| GORE VIABAHN Endoprosthesis with Heparin Normalized: gore viabahn endoprosthesis with heparin |
Device | W. L. Gore & Associates, Inc. | $32.12 | 2 | 2025 |
Source payment records
|
|||||
| OBSIDIO Normalized: obsidio |
Device | Boston Scientific Corporation | $30.85 | 2 | 2025 |
Source payment records
|
|||||
| INTHRILL THROMBECTOMY CATHETER Normalized: inthrill thrombectomy catheter |
Device | Stryker Corporation | $25.49 | 1 | 2025 |
Source payment records
|
|||||
| Serrantor Normalized: serrantor |
Device | Cagent Vascular INC | $23.94 | 2 | 2025 |
Source payment records
|
|||||
| CLOT MANAGEMENT Normalized: clot management |
Device | ARGON MEDICAL DEVICES, INC. | $23.74 | 1 | 2025 |
Source payment records
|
|||||
| PeritX Normalized: peritx |
Device | Bard Peripheral Vascular, Inc. | $23.09 | 1 | 2025 |
Source payment records
|
|||||
| ANGIO-SEAL Normalized: angio seal |
Device | Terumo Medical Corporation | $22.55 | 1 | 2025 |
Source payment records
|
|||||
| General - Therapies Normalized: general therapies |
Device | Boston Scientific Corporation | $20.80 | 1 | 2025 |
Source payment records
|
|||||
| GORE VIATORR TIPS Endoprosthesis with Controlled Expansion Normalized: gore viatorr tips endoprosthesis with controlled expansion |
Device | W. L. Gore & Associates, Inc. | $20.08 | 1 | 2025 |
Source payment records
|
|||||
| EMBRACE HYDROGEL EMBOLIC SYSTEM (HES) Normalized: embrace hydrogel embolic system hes |
Device | INSTYLLA, INC. | $19.25 | 1 | 2025 |
Source payment records
|
|||||
| INSTYLLA DELIVERY KIT Normalized: instylla delivery kit |
Device | INSTYLLA, INC. | $19.25 | 1 | 2025 |
Source payment records
|
|||||
| INSTYLLA MICROCATHETER 1.2 Normalized: instylla microcatheter 1 2 |
Device | INSTYLLA, INC. | $19.25 | 1 | 2025 |
Source payment records
|
|||||
| Ballast 088 Long Sheath Normalized: ballast 088 long sheath |
Device | Balt USA, LLC | $18.51 | 1 | 2025 |
Source payment records
|
|||||
| EVERCROSS Normalized: evercross |
Device | Medtronic, Inc. | $17.72 | 2 | 2025 |
Source payment records
|
|||||
| ADVANCE Normalized: advance |
Device | Cook Medical LLC | $16.54 | 1 | 2025 |
Source payment records
|
|||||
| Optima Coil System Normalized: optima coil system |
Device | Balt USA, LLC | $2.35 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Pantoprazole Sodium | Pantoprazole Sodium | 13 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $3,789.35 · 146 records | Stryker Corporation | ADVANCE, ANGIO-SEAL, ARTIX MT, AZUR CX DETACHABLE, Axios, Ballast 088 Long Sheath, CLOT MANAGEMENT, CONCERTOTM, COOK CELECT, CT THROMBECTOMY SYSTEM KIT, ELUVIA, EMBOLD Fibered, EMBRACE HYDROGEL EMBOLIC SYSTEM (HES), EMPRINT, EVERCROSS, FLOWTRIEVER, FLOWTRIEVER CATHETER, S, GORE VIABAHN Endoprosthesis with Heparin, GORE VIABAHN VBX Balloon Expandable Endo, GORE VIATORR TIPS Endoprosthesis with Controlled Expansion, General - Therapies, HEPZATO KIT, HYDROPEARL, INSTYLLA DELIVERY KIT, INSTYLLA MICROCATHETER 1.2, INTHRILL THROMBECTOMY CATHETER, KYPHON EXPRESS II KYPHOPAK TRAY, MVP, OBSIDIO, Optima Coil System, PROGREAT, PeritX, Prestige Coil System, R2P MISAGO, ROSEN, Revere Hybrid Access Catheter, SMART PORT CT, SYMPHONY CATHETER, Serrantor, Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter, TRINAV INFUSION SYSTEM, VENACORE THROMBECTOMY CATHETER, ZILVER PTX | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error